4.7 Review

(p)ppGpp and Drug Resistance

期刊

JOURNAL OF CELLULAR PHYSIOLOGY
卷 224, 期 2, 页码 300-304

出版社

WILEY
DOI: 10.1002/jcp.22158

关键词

-

资金

  1. National Key Infectious Disease Project [2008ZX10003-006, 2008ZX10003-001]
  2. National Natural Science Foundation [90813019]

向作者/读者索取更多资源

In recent years, emerging and reemerging pathogens resistant to nearly all available antibiotics are on the rise. This limits the availability of effective antibiotics to treat infections, thus it is imperative to develop new drugs. The accumulation of alarmones guanosine tetraphosphate and guanosine pentaphosphate, collectively known as (p)ppGpp, is a global response of bacteria to environmental stress. (p)ppGpp has been documented to be involved in the resistance to beta-lactam and peptide antibiotics. Proposed mechanisms of action include occupation of drug targets, regulation of the expression of virulence determinants, and modification of protein activities. (p)ppGpp analogs might counteract these actions. Several such entities are being tested as new antibiotics. Further insights into the mechanisms of (p)ppGpp-mediated drug resistance might facilitate the discovery and development of novel antibiotics. J. Cell. Physiol. 224: 300-304, 2010. (C) 2010 Wiley-Liss, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

DHX9 interacts with APOBEC3B and attenuates the anti-HBV effect of APOBEC3B

Yanmeng Chen, Bocun Shen, Xiaochuan Zheng, Quanxin Long, Jie Xia, Yao Huang, Xuefei Cai, Deqiang Wang, Juan Chen, Ni Tang, Ailong Huang, Yuan Hu

EMERGING MICROBES & INFECTIONS (2020)

Article Microbiology

Mycobacterium smegmatis msmeg_3314 is involved in pyrazinamide and fluoroquinolones susceptibility via NAD+/NADH dysregulation

Junqi Xu, Yu Chen, Xi Mou, Yu Huang, Shuang Ma, Liyuan Zhang, Yuan Zhang, Quanxin Long, Md Kaisar Ali, Jianping Xie

FUTURE MICROBIOLOGY (2020)

Article Immunology

A Peptide-Based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019

Xue-fei Cai, Juan Chen, Jie-li Hu, Quan-xin Long, Hai-jun Deng, Ping Liu, Kai Fan, Pu Liao, Bei-zhong Liu, Gui-cheng Wu, Yao-kai Chen, Zhi-jie Li, Kun Wang, Xiao-li Zhang, Wen-guang Tian, Jiang-lin Xiang, Hong-xin Du, Jing Wang, Yuan Hu, Ni Tang, Yong Lin, Ji-hua Ren, Lu-yi Huang, Jie Wei, Chun-yang Gan, Yan-meng Chen, Qing-zhu Gao, A-mei Chen, Chang-long He, Dao-Xin Wang, Peng Hu, Fa-Chun Zhou, Ai-long Huang, De-qiang Wang

JOURNAL OF INFECTIOUS DISEASES (2020)

Article Immunology

Difluoromethylornithine, a Decarboxylase 1 Inhibitor, Suppresses Hepatitis B Virus Replication by Reducing HBc Protein Levels

Mao Binli, Wang Zhuo, Pi Sidie, Long Quanxin, Chen Ke, Cui Jing, Huang Ailong, Hu Yuan

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)

Article Gastroenterology & Hepatology

Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx

Sheng-Tao Cheng, Jie-Li Hu, Ji-Hua Ren, Hai-Bo Yu, Shan Zhong, Vincent Kam Wai Wong, Betty Yuen Kwan Law, Wei-Xian Chen, Hong-Mei Xu, Zhen-Zhen Zhang, Xue-Fei Cai, Yuan Hu, Wen-Lu Zhang, Quan-Xin Long, Fang Ren, Hong-Zhong Zhou, Ai-Long Huang, Juan Chen

Summary: A novel small molecule targeting HBx was identified to combat chronic HBV infection, and it was revealed that NQO1 plays a role in HBV replication by regulating the stability of HBx protein.

JOURNAL OF HEPATOLOGY (2021)

Article Multidisciplinary Sciences

Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications

Nan Xiao, Meng Nie, Huanhuan Pang, Bohong Wang, Jieli Hu, Xiangjun Meng, Ke Li, Xiaorong Ran, Quanxin Long, Haijun Deng, Na Chen, Shao Li, Ni Tang, Ailong Huang, Zeping Hu

Summary: Metabolomic data and cytokine/chemokine profiling from stratified COVID-19 patients suggest a correlation between arginine, tryptophan, and purine metabolic pathways with hyperinflammation, potentially offering therapeutic targets for severe COVID-19 patients. Modulating metabolism can significantly impact the release of proinflammatory cytokines by peripheral blood mononuclear cells, indicating a potential strategy for treating fatal cytokine release syndrome in COVID-19.

NATURE COMMUNICATIONS (2021)

Article Cell Biology

Immune memory in convalescent patients with asymptomatic or mild COVID-19

Quan-Xin Long, Yan-Jun Jia, Xin Wang, Hai-Jun Deng, Xiao-Xia Cao, Jun Yuan, Liang Fang, Xu-Rong Cheng, Chao Luo, An-Ran He, Xiao-Jun Tang, Jie-li Hu, Yuan Hu, Ni Tang, Xue-Fei Cai, De-Qiang Wang, Jie Hu, Jing-Fu Qiu, Bei-Zhong Liu, Juan Chen, Ai-long Huang

Summary: This study evaluated the durability of protective immune responses in individuals recovered from asymptomatic or symptomatic SARS-CoV-2 infection approximately 6 months prior. Memory B cell response specific to the RBD of SARS-CoV-2 was relatively low, while T cell responses were observed in individuals recovered from COVID-19, and cross-reactive T cell responses were detected in healthy controls.

CELL DISCOVERY (2021)

Article Microbiology

Mutation Y453F in the spike protein of SARS-CoV-2 enhances interaction with the mink ACE2 receptor for host adaption

Wenlin Ren, Jun Lan, Xiaohui Ju, Mingli Gong, Quanxin Long, Zihui Zhu, Yanying Yu, Jianping Wu, Jin Zhong, Rong Zhang, Shilong Fan, Guocai Zhong, Ailong Huang, Xinquan Wang, Qiang Ding

Summary: This study found that the Y453F mutation in miSARS-CoV-2 enhances the virus's ability to bind to mink ACE2 receptors without compromising its ability to use human ACE2 receptors. Additionally, the Y453F spike shows resistance to convalescent serum, posing a risk for vaccine development.

PLOS PATHOGENS (2021)

Article Microbiology

Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion

Wenlin Ren, Xiaohui Ju, Mingli Gong, Jun Lan, Yanying Yu, Quanxin Long, Devin J. Kenney, Aoife K. O'Connell, Yu Zhang, Jin Zhong, Guocai Zhong, Florian Douam, Xinquan Wang, Ailong Huang, Rong Zhang, Qiang Ding

Summary: The SARS-CoV-2 variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618, recently identified in India, have shown increased transmissibility and evasive immune properties. These variants exhibit enhanced binding affinity with ACE2 orthologs in mice, marmosets, and koalas, while still using human ACE2 with no or slightly increased efficiency. The P681R mutation in these variants facilitates spike cleavage and viral entry. Additionally, the mutations E484Q, T478K, Delta 145-146, or E484K reduce their sensitivity to neutralizing antibodies but they remain sensitive to entry inhibitors like ACE2-Ig decoy receptor. These findings highlight the rapid spread of these variants and suggest the potential use of ACE2-Ig as a broad-spectrum antiviral strategy.
Article Biochemistry & Molecular Biology

Durability of Hepatitis B surface antigen seroclearance in patients experienced nucleoside analogs or interferon monotherapy: A real-world data from Electronic Health Record

Zongqi Shi, Huizhi Zheng, Miaomiao Han, Jieli Hu, Yuan Hu, Xiaosong Li, Wenyan Zhu, Xinjun He, Haijun Deng, Quanxin Long, Ailong Huang

Summary: This retrospective study compares the durability of hepatitis B surface antigen (HBsAg) seroclearance induced by nucleoside analogs (NAs) or interferon (IFN). The study found significant differences in the one-year probabilities of HBsAg seroclearance between patients treated with NAs monotherapy and IFN monotherapy. IFN treatment induced HBsAg seroclearance has higher durability, and the presence of anti-HBs is significantly associated with a longer duration of functional cure.

GENES & DISEASES (2023)

Article Biochemistry & Molecular Biology

APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients

Hongsheng Zhang, Lin Shao, Zhihao Lin, Quan-Xin Long, Huilong Yuan, Lujian Cai, Guangtong Jiang, Xiaoyi Guo, Renzhi Yang, Zepeng Zhang, Bingchang Zhang, Fan Liu, Zhiyong Li, Qilin Ma, Yun-Wu Zhang, Ai-Long Huang, Zhanxiang Wang, Yingjun Zhao, Huaxi Xu

Summary: APOE3 and APOE4 interact with the SARS-CoV-2 receptor ACE2, regulating viral entry and inflammatory response. APOE epsilon 4 carriers may be more susceptible to and develop severe COVID-19.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Article Chemistry, Multidisciplinary

CATCH: high specific transcriptome-focused fusion gene variants discrimination

Rui Yuan, Xiaopeng Bai, Xiaolin Hu, Hong Zhang, Changjun Hou, Quanxin Long, Yang Luo

Summary: This paper introduces a CATCH approach using CRISPR-Cas13a, which combines gene recognition with catalytic hairpin assembly amplification to accurately and impartially identify variants. In a pilot experiment involving 34 clinical samples, this approach achieved 100% accuracy.

CHEMICAL COMMUNICATIONS (2022)

Article Biochemistry & Molecular Biology

Dynamics of neutralizing antibody responses to SARS-CoV-2 in patients with COVID-19: an observational study

Xin Xu, Sheng Nie, Yanqun Wang, Quanxin Long, Hong Zhu, Xiaoyong Zhang, Jian Sun, Qinglang Zeng, Jincun Zhao, Li Liu, Ling Li, Ailong Huang, Jinlin Hou, Fan Fan Hou

Summary: According to a study in Hubei, China, the dynamics of neutralizing antibody (NAbs) response to SARS-CoV-2 in COVID-19 patients showed that NAbs seroconversion occurred at around 5.5 days post onset, with a positivity rate of 52% within the first week, reaching 100% by the third week, and maintaining above 97% for up to 6 months. NAbs peaked in the fourth week and were positively associated with disease severity and age, while inversely associated with serum albumin levels. The half-life of NAbs was 61 days within the first two months, which then slowed to 104 days afterward.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Article Biochemistry & Molecular Biology

Patients with SARS-CoV-2 and HBV co-infection are at risk of greater liver injury

Yong Lin, Jun Yuan, Quanxin Long, Jieli Hu, Haijun Deng, Zhenyu Zhao, Juan Chen, Mengji Lu, Ailong Huang

Summary: This study showed that patients with chronic HBV infection and SARS-CoV-2 co-infection are at higher risk of abnormal liver function tests. However, there were no significant differences in discharge rate or hospitalization duration between the two groups. Enhanced liver injury induced by the co-infection may be related to hepatocyte involvement and inflammatory response.

GENES & DISEASES (2021)

Article Medicine, Research & Experimental

Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation

Jie Hu, Qingzhu Gao, Yang Yang, Jie Xia, Wanjun Zhang, Yao Chen, Zhi Zhou, Lei Chang, Yuan Hu, Hui Zhou, Li Liang, Xiaosong Li, Quanxin Long, Kai Wang, Ailong Huang, Ni Tang

Summary: Viral infection upregulates GLUT1 expression on hepatocytes, facilitating glucose uptake for UDP-GlcNAc synthesis via HBP and increasing protein O-GlcNAcylation to impact HBV replication. O-GlcNAcylation enhances host antiviral response by regulating SAMHD1.

THERANOSTICS (2021)

暂无数据